- Home
- Applications
- monoclonal antibody
Refine by
Monoclonal Antibody Product Applications
11 applications found
Premium
Discover a high-throughput flow imaging microscopy platform for characterizing API aggregates and other particulates in your protein, monoclonal antibody, or antibody-drug conjugate ...
ByYokogawa Fluid Imaging Technologies, Inc. based in Scarborough, MAINE (USA)
Determining adverse immune responses to monoclonal ...
ByAlcyomics Ltd. based in Newcastle Upon Tyne, UNITED KINGDOM
The manufacture of biopharmaceutical agents such as therapeutic monoclonal antibodies, vaccines and cell-based therapies like CAR-T cells require the highest quality control against the contamination of adventitious agents. ...
ByAccuGenomics, Inc. based in Wilmington, NORTH CAROLINA (USA)
Monoclonal antibodies (mAbs) are used to treat patients in a variety of conditions such as infectious disease, cancer, and autoimmunity. Discovery of therapeutic antibodies is a laborious process, that depends on high-throughput screening of antibody candidates to determine antigen specificity. Immune repertoire analysis provides accurate, sensitive, and rapid detection of antibody sequences in panning rounds or exposured animal ...
ByEnpicom B.V. based in s-Hertogenbosch, NETHERLANDS
The modular fashion with which Affilin® ligands can be fused together makes creating multi-specific binders an easy task. Combined with varying linker lengths, composition, and orientation, plus the optional addition of further accessory modules, our Navigo experts build the designed molecules as previously planned on the drawing ...
ByNavigo Proteins GmbH based in Halle, GERMANY
No single preventive health intervention is more cost-effective than immunization. Immune repertoire analysis has taken a predominant role in the development of vaccination strategies against infectious disease and has enabled characterization of the immune response against pathogens at high ...
ByEnpicom B.V. based in s-Hertogenbosch, NETHERLANDS
NorthStar Medical Radioisotopes is poised to become the first-in-class supply chain for the future of therapeutic radiopharmaceuticals. Check back for progress on our non-carrier-added (n.c.a) Ac-225 and Cu-67 development ...
ByNorthStar Medical Radioisotopes, LLC based in Beloit, WISCONSIN (USA)
As the COVID-19 pandemic continues, the SARS-CoV-2 virus is likely to become endemic with emerging novel variants, some of them seasonal. Updates to the various vaccines will be required, as will a range of anti-virals with a variety of mechanisms of action, for use in early infection and in hospitalizated patients, much like oseltamivir (Tamiflu) is used in certain populations for seasonal ...
ByCyrus Biotechnology Inc. based in Seattle, WASHINGTON (USA)
2A Pharma’s vaccine platform is based on mutated parvoviral particles consisting essentially of one protein. The particles contain no viral genome and are replicative defective and non-pathogenic. The particle capsid surface has repetitive, immunogenic sites, where peptides of interest can be inserted and allows us to generate monovalent or bivalent vaccines as required. Each peptide of interest will be presented 60 times on the capsid surface and both the innate and adaptive immune systems are activated to ...
By2A Pharma ApS based in Aalborg Øst, DENMARK
Fast at-line determination of product quality and biological relevant status information on process ...
Bylino Biotech AG based in Zurich, SWITZERLAND
Simple and robust determination of critical quality attributes in ...
Bylino Biotech AG based in Zurich, SWITZERLAND